Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCentre Hospitalier Universitaire de Besancon

About this trial

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria.

These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies.

It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered

Patient admitted between 1st January 2012 to 31st December 2017

Disqualifiers

None

Trial population

All patients treated in medical and surgical resuscitation units of Besançon and Dijon university hospitals during the study period (from 01/01/2012 to 31/12/2017) are concerned.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Survival at 90 days after leaving ICU

All-cause mortality 90 days after leaving ICU

Time frame
Day 90

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.